Viewing Study NCT04040894


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-01-06 @ 3:46 PM
Study NCT ID: NCT04040894
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2024-06-20
First Post: 2019-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module